
Identification
CAS Number
155206-00-1Name
BimatoprostSynonyms
(5Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl}-N-ethyl-5-heptenamid [German] [ACD/IUPAC Name] (5Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl}-N-ethyl-5-heptenamide [ACD/IUPAC Name] (5Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phényl-1-pentén-1-yl]cyclopentyl}-N-éthyl-5-hepténamide [French] [ACD/IUPAC Name] (5Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide 5-Heptenamide, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-, (5Z)- [ACD/Index Name] bimatoprost [French] [INN] bimatoprost [Spanish] [INN] Bimatoprost [USAN] [Wiki] bimatoprostum [Latin] [INN] Lumigan [Trade name] биматопрост [Russian] [INN] بيماتوبروست [Arabic] [INN] 贝美前列素 [Chinese] [INN] (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl]-N-ethylhept-5-enamide (Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)cyclopentyl)-N-ethylhept-5-enamide (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenyl-pent-1-enyl]cyclopentyl]-N-ethyl-hept-5-enamide [155206-00-1] 155206-00-1 [RN] 267244-98-4 [RN] 5-Heptenamide, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-, (5Z)- 5-Heptenamide, 7-(3,5-dihydroxy-2-(3-hydrdoxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-, (1R-(1α(Z),2β(1E,3S*),3α,5α))- AGN 192024|LS-181817|Lumigan® Lumigan (TN) Lumigan® Lumigan; Latisse; AGN 192024; bimatoprostum; Lumigan (TN); AC1NSJUW; AGN-192024; UNII-QXS94885MZ MFCD03411999 [MDL number] UNII-QXS94885MZMolecular Structure
SMILES
CCNC(=O)CCC/C=C\C[C@H]1[C@H](C[C@H]([C@@H]1/C=C/[C@H](CCc2ccccc2)O)O)OStdInChI
InChI=1S/C25H37NO4/c1-2-26-25(30)13-9-4-3-8-12-21-22(24(29)18-23(21)28)17-16-20(27)15-14-19-10-6-5-7-11-19/h3,5-8,10-11,16-17,20-24,27-29H,2,4,9,12-15,18H2,1H3,(H,26,30)/b8-3-,17-16+/t20-,21+,22+,23-,24+/m0/s1StdInChIKey
AQOKCDNYWBIDND-FTOWTWDKSA-NMolecular Formula
C25H37NO4Molecular Weight
415.57Properties
Appearance
White powderSafety Data
Personal Protective Equipment
Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filterRIDADR
NONH for all modes of transportWGK Germany
3MSDS
MSDS of Bimatoprost CAS 155206-00-1Specifications and Other Information of Our Bimatoprost CAS 155206-00-1
Standard
Enterprise standardCertificate
GMPIdentification Methods
HNMR/HPLCPurity
99.5% minSpecific Optical Rotation
+33.0-+37.0°Heavy Metals
10ppmmaxResidue on Ignition
0.1%maxSingle Impurity
0.1%maxTotal Impurities
0.5%maxStorage
Store at the 2-8℃Adding proportion for reference
0.03%/100mlApplication
Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes. It has also been used and prescribed off-label to lengthen eyelashes.General View of Documents



Normal Phase HPLC of Bimatoprost CAS 155206-00-1



Reverse Phase HPLC of Bimatoprost CAS 155206-00-1



IR of Bimatoprost CAS 155206-00-1